Cardurion Pharmaceuticals Inc

Cardurion Pharmaceuticals, Inc. develops biotechnology solutions for cardiovascular therapeutics. The Company focuses on clinical development of PDE9 and CaMKII inhibitors, conducts global multi-center trials, and discovers novel treatments for heart conditions. Cardurion Pharmaceuticals Inc serves patients with heart failure and arrhythmias in Europe, Japan, and the United States.